National Briefing | Health: FDA Panel Supports Ortho Evra Birth Control Patch

Monday, December 12, 2011 - 21:00 in Health & Medicine

The Food and Drug Administration’s panel of reproductive health experts voted that the benefits of Ortho Evra outweigh its risks, like a potentially higher likelihood of blood clots.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net